Minneapolis, MN – AdvaHealth Solutions, a leader in cloud-native enterprise imaging solutions, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the sale and distribution of AdvaView, its cloud-native and zero-footprint diagnostic viewer.

Building upon AdvaHealth’s established FDA-cleared healthcare software, the AdvaView FDA clearance reflects the company’s continued investment in regulatory quality as medical device requirements evolve. It also marks an important milestone as AdvaHealth expands its medical imaging platform for radiologists and imaging organizations in the United States.

AdvaView provides diagnostic viewing through browser-based, zero-footprint architecture, eliminating the need to install and maintain client software across individual workstations. This allows radiologists to access a consistent viewing environment across reading rooms, home offices, and distributed reading locations.

"Securing FDA 510(k) clearance for AdvaView reinforces our unyielding commitment to regulatory compliance and uncompromising quality. In clinical informatics, innovation is only as valuable as the trust behind it. We are dedicated to ensuring that every tool we deliver meets the highest standards of quality and compliance so that we can achieve excellence for clinicians and the patients they serve."

AdvaView brings diagnostic viewing into a unified workflow with the AdvaPACS platform, connecting image management, radiology workflow, and enterprise imaging capabilities in one environment.

---